These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 17221878

  • 1. Polyglucosan body disease myopathy: an unusual presentation.
    Vucic S, Pamphlett R, Wills EJ, Yiannikas C.
    Muscle Nerve; 2007 Apr; 35(4):536-9. PubMed ID: 17221878
    [Abstract] [Full Text] [Related]

  • 2. Development of polyglucosan inclusions in skeletal muscle.
    Valentine BA, Cooper BJ.
    Neuromuscul Disord; 2006 Oct; 16(9-10):603-7. PubMed ID: 16919952
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adult polyglucosan body myopathy with subclinical peripheral neuropathy: case report and review of diseases associated with polyglucosan body accumulation.
    Weis J, Schröder JM.
    Clin Neuropathol; 1988 Oct; 7(6):271-9. PubMed ID: 2852083
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Polysaccharide amylopectin-type storage myopathy].
    Calore EE, Pellissier JF, Figarella-Branger D, de Barsy T, Pouget J, Serratrice G.
    Rev Neurol (Paris); 1992 Oct; 148(11):696-703. PubMed ID: 1303560
    [Abstract] [Full Text] [Related]

  • 7. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP.
    Neurology; 2009 Jun 02; 72(22):1948-52. PubMed ID: 19487653
    [Abstract] [Full Text] [Related]

  • 8. Polyglucosan myopathy and functional characterization of a novel GYG1 mutation.
    Hedberg-Oldfors C, Mensch A, Visuttijai K, Stoltenburg G, Stoevesandt D, Kraya T, Oldfors A, Zierz S.
    Acta Neurol Scand; 2018 Mar 02; 137(3):308-315. PubMed ID: 29143313
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Motor neuron disorder simulating ALS induced by chronic inhalation of pyrethroid insecticides.
    Doi H, Kikuchi H, Murai H, Kawano Y, Shigeto H, Ohyagi Y, Kira J.
    Neurology; 2006 Nov 28; 67(10):1894-5. PubMed ID: 17130437
    [No Abstract] [Full Text] [Related]

  • 11. Electrophysiology extends the phenotypic spectrum of X-linked myopathy with excessive autophagy.
    Munteanu I, Ackerley CA, Mnatzakanian GN, Kissel JT, Minassian BA.
    Neurology; 2005 Mar 08; 64(5):927-8. PubMed ID: 15753448
    [No Abstract] [Full Text] [Related]

  • 12. Acquired rippling muscle disease with myasthenia gravis.
    Greenberg SA.
    Muscle Nerve; 2004 Jan 08; 29(1):143-6. PubMed ID: 14694511
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Critical illness myopathy: further evidence from muscle-fiber excitability studies of an acquired channelopathy.
    Allen DC, Arunachalam R, Mills KR.
    Muscle Nerve; 2008 Jan 08; 37(1):14-22. PubMed ID: 17763454
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proteomic profiling of polyglucosan bodies associated with glycogenin-1 deficiency in skeletal muscle.
    Visuttijai K, Hedberg-Oldfors C, Costello DJ, Bermingham N, Oldfors A.
    Neuropathol Appl Neurobiol; 2024 Jun 08; 50(3):e12995. PubMed ID: 38923610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.